Pharmacology British Journal of Pharmacology (Wiley)
Vitamin E directly blocks cIAP1 degradation and cell death signaling
- A screen found that vitamin E blocks TNF-α and SMAC mimetic-induced cell death through a mechanism separate from its antioxidant role.
- Binding assays indicate it competitively engages the BIR3 domain of cIAP1, preventing its degradation.
- Preserved cIAP1 limits formation of the RIPK1-dependent death complex, and treatment eased colitis severity in mice.
The colitis benefit is attributed to cIAP1 rather than redox, yet a lipophilic vitamin binding the BIR3 pocket needs a proper control to back that up. Non-antioxidant tocopherol analogs and cIAP1-knockout cells would test it. Also worth testing is whether vitamin E blunts SMAC mimetics in tumor models, the first clinically relevant consequence of this interaction.
Paper: British Journal of Pharmacology (Wiley) ↗ α‐tocopherol (Vitamin E) inhibits second mitochondria‐derived activator of caspases (SMAC) mimetic‐induced cell death by directly targeting cIAP1 degradation